Stock Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Foundation Announces Second Round of Grants in Partnership with Campaign for Tobacco-Free Kids

[PR Newswire] – WOONSOCKET, R.I., March 16, 2016 /PRNewswire/ — The CVS Health Foundation, a private foundation created by CVS Health (CVS), today announced the second round of grants awarded in partnership with the Campaign for Tobacco-Free Kids through the “Making the Next Generation Tobacco-Free” grant program. The new grants are part of Be The First, CVS Health’s $50 million, five-year initiative to help deliver the nation’s first tobacco-free generation, and extend the company’s commitment to help people lead tobacco-free lives. The announcement of a new group of grantees coincides with Kick Butts Day, the Campaign for Tobacco Free Kids’ national day of activism that empowers youth to stand out, speak up and mobilize their communities in fighting tobacco use. In partnership with Campaign for Tobacco-Free Kids, CVS Health Foundation has committed $5 million in grants over five years to nonprofit organizations that are committed to educating young people about the dangers of tobacco. Read more on this. CVS Health Corporation (CVS) , with a current market cap of $111.05B, started trading this morning at $100.23. Today’s price range has been between $100.86 and $101.35 per share with a trailing 52-week range being $81.37 to $113.65. CVS shares are currently priced at 17.07x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 9.15x earnings multiple. And for passive income investors, the company pays shareholders $1.70 per share annually in dividends, yielding 1.69%. Consensus earnings for the current quarter by the 25 sell-side analysts covering the stock is an estimate of $1.16 per share, which would be $0.02 better than the year-ago quarter and a $0.10 sequential decrease. Furthermore, our analysis shows the full-year EPS estimate to be $5.82, which would be a $0.66 improvement when compared to the last year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $42.99 Billion. If reported, that would be a 18.33% increase over the year-ago quarter. More recently, Atlantic Equities Initiated CVS at Overweight (Feb 3, 2016). Previously, Robert W. Baird Initiated CVS at to Outperform. Given all the information above, we should disclose to readers that the average price target is $112.06, which is 11.80% above than it opened this morning. See more in (NYSE:CVS) Similar Articles: Company Update (NYSE:CVS): CVS Health Makes $50 Million Five-Year Commitment to Deliver the Nation’s First Tobacco-Free Generation As Next Step Toward Smoke-Free Living Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Announces Strategic Partnerships with Two National Multicultural Nursing Associations Market Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Corporation Announces Expiration of Exchange Offers and Consent Solicitations